Study led by UNC Lineberger Comprehensive Cancer Center members Hanna Sanoff and Stacie Dusetzina found that the liver cancer drug can have serious side effects and significant out-of-pocket costs for advanced liver cancer patients.
Promise of nearly a year of life on targeted drug not reality for all liver cancer patients